| For: | Han MAT, Olivo R, Choi CJ, Pyrsopoulos N. De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation. World J Hepatol 2021; 13(12): 1991-2004 [PMID: 35070003 DOI: 10.4254/wjh.v13.i12.1991] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i12/1991.htm |
| Number | Citing Articles |
| 1 |
Iyiad Alabdul Razzak, Michael P. Curry, Michelle Lai, Hirsh D. Trivedi. Post-Transplant Hepatic Steatosis: A Condition Not to Overlook. Journal of Clinical Medicine 2023; 12(23) doi: 10.3390/jcm12237340
|
| 2 |
Serena Bansal, Maryam Naghibzadeh, Saba Maleki, Naomi Hlaing Than, Shiyi Chen, Sameera Rizvi, Masoom Haidar, Mamatha Bhat. Myosteatosis as a prognostic biomarker for post-transplant survival and cardiometabolic outcomes: A retrospective study. Canadian Liver Journal 2026; doi: 10.3138/canlivj-2025-0054
|
| 3 |
Jing Kang, Ji-Qiao Zhu, Yan Wang, Qiang He. Effect of Immunosuppressive Regimens on Metabolic Dysfunction-associated Fatty Liver Disease Following Liver Transplantation. Journal of Clinical and Experimental Hepatology 2025; 15(1) doi: 10.1016/j.jceh.2024.102387
|
| 4 |
Filippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, Pietro Andreone, Stefano Gitto. Metabolic Disorders in Liver Transplant Recipients: The State of the Art. Journal of Clinical Medicine 2024; 13(4) doi: 10.3390/jcm13041014
|
| 5 |
Harry Crane, Cameron Gofton, Ankur Sharma, Jacob George. MAFLD: an optimal framework for understanding liver cancer phenotypes. Journal of Gastroenterology 2023; 58(10) doi: 10.1007/s00535-023-02021-7
|
| 6 |
Laxmi Parsa, Sanjaya K. Satapathy. Fundamentals of Transplant Hepatology. 2026; doi: 10.1007/978-981-95-2624-6_37
|